Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Baxter International reported $12.03B in Current Assets for its fiscal quarter ending in September of 2023.

Current Assets Change Date
AngioDynamics USD 175.48M 11.93M Jun/2023
AtriCure USD 252.72M 14.74M Sep/2023
Avanos Medical USD 524.6M 17.7M Sep/2023
Baxter International USD 12.03B 3.83B Sep/2023
Becton, Dickinson and Co. USD 8.68B 88M Sep/2023
Cooper Companies USD 1.7B 6.1M Sep/2023
Dexcom USD 4.7B 304.5M Sep/2023
Edwards Lifesciences USD 4.07B 420.5M Sep/2023
Globus Medical USD 1.92B 707.33M Sep/2023
Halozyme Therapeutics USD 879.01M 113.26M Sep/2023
ICU Medical USD 1.22B 25.33M Sep/2023
Inogen USD 225.27M 43.96M Sep/2023
Insulet USD 1.47B 49.6M Sep/2023
Integra LifeSciences USD 1.03B 24.03M Sep/2023
Intuitive Surgical USD 8.9B 871.1M Sep/2023
Laboratory Of America USD 3.95B 1.17B Sep/2023
Masimo USD 1.24B 29.3M Sep/2023
Merit Medical Systems USD 585.32M 9.59M Sep/2023
Quest Diagnostics USD 1.82B 82M Sep/2023
Smith & Nephew USD 3.88B 22M Jun/2023
Stryker USD 11.04B 894M Sep/2023
Tandem Diabetes Care USD 758.14M 6.16M Sep/2023
Teleflex USD 2.1B 651.47M Sep/2023
Terumo JPY 684.24B 50.56B Sep/2023
Zimmer Biomet Holdings USD 4.37B 15.9M Sep/2023